Forsta AP Fonden Sells 11,700 Shares of Avantor, Inc. $AVTR

Forsta AP Fonden lessened its position in Avantor, Inc. (NYSE:AVTR) by 2.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 402,600 shares of the company’s stock after selling 11,700 shares during the period. Forsta AP Fonden owned approximately 0.06% of Avantor worth $5,419,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Rise Advisors LLC acquired a new position in Avantor during the 1st quarter worth approximately $25,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Avantor by 288.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock worth $28,000 after purchasing an additional 1,263 shares in the last quarter. Wealthquest Corp acquired a new position in Avantor during the first quarter worth $34,000. FNY Investment Advisers LLC bought a new position in Avantor in the second quarter valued at $36,000. Finally, Spire Wealth Management acquired a new stake in Avantor in the 2nd quarter valued at $47,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the subject of several analyst reports. Morgan Stanley decreased their price objective on Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a report on Monday, August 4th. Jefferies Financial Group restated a “hold” rating on shares of Avantor in a research note on Friday, August 1st. Evercore ISI lowered their price target on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Thursday, October 30th. Barclays reissued an “equal weight” rating and issued a $12.00 price objective (down previously from $15.00) on shares of Avantor in a report on Thursday, October 30th. Finally, Robert W. Baird upped their price target on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $14.42.

Avantor Stock Performance

AVTR opened at $11.38 on Friday. The company has a market cap of $7.76 billion, a price-to-earnings ratio of -87.50, a PEG ratio of 4.03 and a beta of 1.00. The company’s fifty day moving average price is $12.99 and its two-hundred day moving average price is $13.05. Avantor, Inc. has a 1-year low of $10.82 and a 1-year high of $23.32. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The company’s revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.26 EPS. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. On average, analysts expect that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insider Activity

In other news, Director Gregory L. Summe bought 100,000 shares of the stock in a transaction dated Thursday, October 30th. The stock was bought at an average price of $11.25 per share, for a total transaction of $1,125,000.00. Following the completion of the acquisition, the director directly owned 300,000 shares in the company, valued at approximately $3,375,000. This trade represents a 50.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.20% of the stock is currently owned by insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.